Hansen Medical Files 510K For Neurological Indication For Magellan Product Line

(RTTNews) - Hansen Medical, Inc. (HNSN) provided an update on the status of its key corporate initiative to expand the utility and regulatory labeling of the Magellan product line.

Hansen Medical said it recently submitted a 510k to the FDA for a neurological indication for the Magellan Robotic System. If successful, the Magellan Robotic System would be fully indicated for applications in peripheral vascular and neurological procedures.

Hansen Medical's Magellan Robotic System is intended to be used to facilitate navigation in the peripheral vasculature and subsequently provide a conduit for manual placement of therapeutic devices. The system is designed to deliver predictability, control and catheter stability to endovascular procedures.

Cary Vance, Hansen Medical's President and Chief Executive Officer said, "We anticipate that an added neurological indication would allow us to bring the benefits of robotics to a new specialty of physicians who could, in turn, offer robotic solutions to a new patient population. We are excited by the potential to expand the procedure base in which robotics can play a role."